Western Pennsylvania Cancer Institute — Pittsburgh, Pennsylvania

Western Pennsylvania Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Western Pennsylvania Cancer Institute has participated in 21 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes, Disease, Hodgkin, Lung Cancer.

Sponsors: Celgene Corporation, Seagen Inc., Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Western Pennsylvania Cancer Institute?

Western Pennsylvania Cancer Institute has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Western Pennsylvania Cancer Institute conducted?

Western Pennsylvania Cancer Institute has 21 clinical trials on record. Their work covers Myelodysplastic Syndromes, Disease, Hodgkin, Lung Cancer.

Is Western Pennsylvania Cancer Institute accredited by Crixeo Health?

Yes — Western Pennsylvania Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Western Pennsylvania Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.